comparemela.com

Latest Breaking News On - Amneal pharmaceuticals company profile - Page 3 : comparemela.com

StockNews com Begins Coverage on Amneal Pharmaceuticals (NASDAQ:AMRX)

StockNews.com assumed coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a research note published on Wednesday morning. The firm issued a buy rating on the stock. Separately, Truist Financial boosted their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the stock a buy rating in a research note on […]

Amneal Pharmaceuticals (NASDAQ:AMRX) Coverage Initiated by Analysts at StockNews com

StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a report published on Wednesday. The firm issued a buy rating on the stock. Separately, Truist Financial upped their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in a research report on Wednesday, November […]

Amneal Pharmaceuticals (NASDAQ:AMRX) Coverage Initiated by Analysts at StockNews com

StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a buy rating on the stock. Separately, Truist Financial upped their price objective on shares of Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in […]

Amneal Pharmaceuticals, Inc (NASDAQ:AMRX) Receives $4 80 Average Target Price from Analysts

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.